Beta Bionics, Inc. earnings releases BBNX

Beta Bionics, Inc. last reported quarterly results on Oct 27, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $35.5 million (+30.3% year over year) and diluted EPS of -$0.52. It usually reports 8–29 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 7, 2027.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 8–29 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Oct 27, 2026
27 days after quarter end
Q3 FY2026
ended Sep 30, 2026
36
+30.3%
-24
-71.4%
-0.52
-57.6%
Jul 29, 2026
29 days after quarter end
Q2 FY2026
ended Jun 30, 2026
32
+37.8%
-23
-38.7%
-0.53
-35.9%
Apr 21, 2026
21 days after quarter end
Q1 FY2026
ended Mar 31, 2026
28
+56.6%
-22
+23.6%
-0.49
+47.3%
Jan 8, 2026
8 days after quarter end
Q4 FY2025
ended Dec 31, 2025
32
-13
-0.30
Oct 28, 2025
28 days after quarter end
Q3 FY2025
ended Sep 30, 2025
27
-14
-0.33
Jul 29, 2025
29 days after quarter end
Q2 FY2025
ended Jun 30, 2025
23
-17
-0.39
May 6, 2025
36 days after quarter end
Q1 FY2025
ended Mar 31, 2025
18
-29
-0.93

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
BBNX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Irvine, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1674632
Former names
Beta Bionics, Inc (until Jan 6, 2025)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.